|
2024
|
Invention
|
Influenza hemagglutinin constructs and compositions. The present disclosure relates to influenza ... |
|
2023
|
Invention
|
Novel vsv virus formulations. Described herein are novel compositions comprising a virus or viral... |
|
|
P/S
|
Auto-injectors pre-filled with pharmaceuticals for the prevention and treatment of disorders caus... |
|
2022
|
Invention
|
Vaccine compositions.
The present invention relates to a vaccine composition comprising an influ... |
|
|
Invention
|
Vaccine compositions. The present invention relates to a vaccine composition comprising an influe... |
|
|
Invention
|
Microsphere formulations comprising nalmefene andmethods for making and using the same.
Microsph... |
|
|
Invention
|
Microsphere formulations comprising nalmefene and methods for making and using the same. Microsph... |
|
|
Invention
|
Valiolamine derivatives as glucosidase inhibitors.
This disclosure is directed to N-substituted ... |
|
|
Invention
|
Valiolamine derivatives as glucosidase inhibitors. This disclosure is directed to N-substituted v... |
|
|
Invention
|
Modified sars-cov-2 spike polypeptides and nanoparticles thereof. The present disclosure is direc... |
|
|
P/S
|
pharmaceutical and veterinary preparations for diseases and conditions associated with exposure t... |
|
2021
|
Invention
|
Stabilized alkyl nitrite compositions.
This disclosure describes a composition comprising an alk... |
|
|
Invention
|
Stabilized alkyl nitrite compositions. This disclosure describes a composition comprising an alky... |
|
|
Invention
|
Autoinjector for administration of medications.
An autoinjector for administering medications. T... |
|
|
Invention
|
Autoinjector for administration of medications. An autoinjector for administering medications. Th... |
|
|
Invention
|
Deoxynojirimycin derivatives as glucosidase inhibitors. The present application provides novel im... |
|
|
Invention
|
Opioid antagonist formulations.
The present disclosure relates to pharmaceutical compositions co... |
|
|
Invention
|
Opioid antagonist formulations. The present disclosure relates to pharmaceutical compositions com... |
|
|
Invention
|
Autoinjector |
|
2018
|
Invention
|
Antimicrobial 4-oxoquinolizines.
This invention provides novel 4-oxoquinolizine compounds and th... |
|
|
Invention
|
2-pyridone antimicrobial compositions. Disclosed herein are compounds of Formula I
2, X, and Y a... |
|
2017
|
Invention
|
Methods of treating zika virus infection.
This disclosure provides methods for treating or preve... |
|
|
Invention
|
2-pyridone antimicrobial compositions.
Disclosed herein are compounds of Formula I
Disclosed h... |
|
2016
|
Invention
|
Antimicrobial 4-oxoquinolizines. This invention provides novel 4-oxoquinolizine compounds and the... |
|
2015
|
Invention
|
Iminosugars useful for the treatment of viral diseases. Formula IA, and their use for treating vi... |
|
2014
|
Invention
|
Temperature stable vaccine formulations. Vaccine antigen formulations that are stable after under... |
|
|
Invention
|
Deoxynojirimycin derivatives and methods of their using. The present application provide novel im... |
|
2013
|
Invention
|
Temperature stable vaccine formulations.
Formulations of vaccine antigen, such as anthrax protec... |
|
|
Invention
|
Temperature stable vaccine formulations. Formulations of vaccine antigen, such as anthrax protect... |
|
2011
|
Invention
|
2-pyridone antimicrobial compositions. Described are a series of 2-pyridone compounds as a potent... |
|
|
Invention
|
Ectodomains of influenza matrix 2 protein, expression system, and uses thereof.
The present inve... |
|
|
Invention
|
Ectodomains of influenza matrix 2 protein, expression system, and uses thereof. The present inven... |
|
2009
|
Invention
|
Chlamydia vaccine comprising htra polypeptides. The present invention provides vaccine compositio... |
|
|
Invention
|
Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof. M. ... |
|
|
Invention
|
Recombinant modified vaccinia virus ankara (mva) expressing chlamydia polypeptide antigens. The p... |
|
|
Invention
|
Combinatorial library approach to iminocyclitols with biological activity. A method of synthesizi... |
|
2008
|
Invention
|
Antibodies against anthrax protective antigen.
A highly efficient method for generating human an... |
|
|
Invention
|
Vaccines against chlamydia infection.
The present invention is directed to providing a vaccine t... |
|
|
Invention
|
Vaccines against chlamydia infection. The present invention is directed to providing a vaccine to... |
|
|
Invention
|
Chlamydia vaccine comprising htra polypeptides.
The present invention provides vaccine compositi... |
|
|
P/S
|
Smallpox vaccines. |
|
|
P/S
|
Smallpox vaccines. |
|
2007
|
Invention
|
Moraxella catarrhalis protein, nucleic acid sequence and uses thereof. Moraxella infections in an... |
|
|
P/S
|
smallpox vaccines |
|
2004
|
Invention
|
Vaccinia virus strains. The invention provides attenuated vaccinia virus vaccines that can be use... |
|
2000
|
Invention
|
Chlamydia protein, gene sequence and the uses thereof. Chlamydia. |
